- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.06. | Camurus and Eli Lilly collaborate on long-acting incretin products | ||
| 03.06. | Zealand Pharma submits glepaglutide MAA for short bowel syndrome | ||
| 02.06. | Mabwell's Mailisheng receives NMPA marketing approval | ||
| 30.05. | US FDA approves Alcon's Tryptyr ophthalmic solution for Dry Eye Disease | ||
| 29.05. | Archeus Technologies partners with WARF to advance ART-101 for prostate cancer | ||
| 28.05. | GRIN Therapeutics and Angelini Pharma collaborate on radiprodil development | ||
| 27.05. | Henlius receives ODD for HLX22 from European Commission | ||
| 26.05. | Orion partners with Shilpa Biocare for recombinant human albumin in Europe | ||
| 23.05. | Genentech gains FDA approval for diabetic retinopathy treatment | ||
| 22.05. | Juvenescence secures $76m funding to advance therapeutic pipeline | ||
| 21.05. | Mirai Bio and Thermo Fisher to advance genetic medicine development | ||
| 20.05. | FDA grants fast track status to Zai Lab's lung cancer treatment | ||
| 19.05. | Canadian research initiative secures grant for paediatric brain cancer | ||
| 16.05. | FDA grants RMAT to BrainChild Bio's CAR T-cell therapy for DIPG | ||
| 15.05. | AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas | ||
| 14.05. | FDA to review Regenxbio's gene therapy BLA for Hunter syndrome | ||
| 13.05. | InnoCare's Mesutoclax obtains breakthrough therapy designation in China | ||
| 12.05. | Sirius secures $50m to advance siRNA therapeutics for cardiometabolic disorders | ||
| 09.05. | MIRA secures board approval to buy SKNY Pharmaceuticals | ||
| 08.05. | Evotec secures $2.5m grant for TB treatment development | ||
| 07.05. | FDA grants fast track status to Alterity's multiple system atrophy treatment | ||
| 06.05. | USPTO grants two additional patents to Moleculin's drug candidate | ||
| 05.05. | PCI completes acquisition of sterile fill-finish CDMO Ajinomoto Althea |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .